Call 0161 423 4208

SHOT Participation Benchmarking

SHOT has been producing participation benchmarking  reports for each reporting organisation since 2010. From 2013 this  data will no longer be anonymised and data for all reporting organisations will be available online to all registered reporters through the password protected link below.

REGISTERED REPORTERS: Log in here to view SHOT participation benchmarking data. You will be able to view all reports, as well as your own organisation’s report. If you don’t have login details, please contact the SHOT Office, 0161 423 4208 or shot@nhsbt.nhs.uk

Reporting organisations have been grouped in two separate ways:

  • clustered by size according to the number of blood components issued to the Trust/Health Board (issue data used as a surrogate for usage data)
  • geographically, by UK country and where applicable, grouped according to their Regional Transfusion Committee (RTC)

There are comparative data charts within each usage cluster and geographical group to enable an individual organisation to benchmark itself against its peers.
Data has been subcategorised into the main incident types:

  • Pathological Reaction (broadly equivalent to unpredictable clinical reactions)
  • Adverse Event (broadly equivalent to avoidable errors)
  • Near Miss
  • Anti-D
  • Withdrawn
  • Other (= uncommon incidents such as transfusion transmitted infections)

All data are presented as number of SHOT reports per 1000 blood components issued or per 100 units of anti-D immunoglobulin (Ig) issued. This allows a more accurate comparison between organisations of different sizes.

Data are presented in the following formats:

1. Individual summary table

Each reporting organisation will receive a report, subcategorised into the main incident types, containing:

  • The organisation’s code number, so your organisation’s data can be identified in the comparison charts.
  • Total number of reports submitted in the year 2013 and a comparison with the previous year “Increase/decrease from 2012” .
  • Average number of reports for the relevant UK-wide blood component usage group (see item 2 below).
  • Average number of reports for the relevant geographical area (see item 3 below).
  • Total number of reports submitted expressed as per 1000 blood components issued or per 100 units of anti-D Ig used, plus a comparison with the previous year “Increase/decrease from 2012”.
  • Average reports per 1000* for the relevant geographical area (*per 100 for Anti-D Ig)
  • Average reports per 1000* for the relevant component issue cluster(*per 100 for Anti-D Ig)

There are a few organisations with such low component usage (less than 1000 components per annum) that meaningful benchmarked comparisons were not feasible. These organisations will receive only the summary table report and will not be featured on the comparison graphs.

2. Total reports by usage size of organisation

A graphical representation of the total reports submitted by all organisations within a usage cluster. Organisations have been allocated to a cluster according to total blood components issued to that organisation per annum. These clusters are similar to, but not identical to those used by the Blood Stocks Management Scheme (BSMS).

  • Very low: up to 1000 components received per annum
  • Low: 1001-8000 components received per annum
  • Medium: 8001-12,000 components received per annum
  • High: 12001-20,000 components received per annum
  • Very high: >20,000 components received per annum

3. Reports by geographical location

A graphical representation of the total reports submitted by all organisations within a geographical area defined as either the devolved UK country or the RTC.

4. A summary of participation levels for all RTCs and devolved countries

A graphical representation of the total reports submitted by each devolved UK country or RTC.

How to use this benchmarked participation data

The quality of SHOT data can only be assured if there is adequate involvement throughout the transfusion community to ensure all incidents are reported accurately. Therefore, please use the attached data to monitor your own organisation s level of participation in the SHOT scheme in comparison to organisations of similar usage. The results for an individual organisation should be interpreted with caution, based on knowledge of your local transfusion practice. If your organisation submitted more reports than similar organisations, then this may either reflect a real problem with transfusion safety, or alternatively that you are better at recognising and reporting transfusion related reactions and adverse events. On the other hand if your organisation submitted fewer reports than similar organisations, then this may either reflect good practice or could be that reactions and adverse events are under-recognised and under-reported.

Frequently asked questions

Answers to some common questions about the SHOT Participation Benchmarking project have been compiled in the document below.

SHOT Participation Benchmarking FAQs